{"id":"https://openalex.org/W3083136296","doi":"https://doi.org/10.1158/1538-7445.am2020-6532","title":"Abstract 6532: HFB9-2: A novel Gal-9 neutralizing antibody to reverse immune suppression in the tumor microenvironment","display_name":"Abstract 6532: HFB9-2: A novel Gal-9 neutralizing antibody to reverse immune suppression in the tumor microenvironment","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083136296","doi":"https://doi.org/10.1158/1538-7445.am2020-6532","mag":"3083136296"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-6532","doi":"https://doi.org/10.1158/1538-7445.am2020-6532","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6532","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031325544","display_name":"Germain Margall-Ducos","orcid":"https://orcid.org/0009-0000-6815-1794","observed_orcids":["https://orcid.org/0009-0000-6815-1794"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Germain Margall","raw_affiliation_strings":["1Hifibio, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hifibio, Paris, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032922968","display_name":"Rachel Pacherie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Pacherie","raw_affiliation_strings":["1Hifibio, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hifibio, Paris, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001421555","display_name":"Julie Prigent","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie Prigent","raw_affiliation_strings":["1Hifibio, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hifibio, Paris, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100550736","display_name":"Zhou He","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"He Zhou","raw_affiliation_strings":["2Hifibio, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Hifibio, Shanghai, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112834836","display_name":"Francisco Adri\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francisco Adrian","raw_affiliation_strings":["3Hifibio, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hifibio, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076762162","display_name":"Liang Schweizer","orcid":"https://orcid.org/0000-0002-0903-4077","observed_orcids":["https://orcid.org/0000-0002-0903-4077"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liang Schweizer","raw_affiliation_strings":["3Hifibio, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hifibio, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063153590","display_name":"Andreas Raue","orcid":"https://orcid.org/0000-0002-9198-2489","observed_orcids":["https://orcid.org/0000-0002-9198-2489"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Raue","raw_affiliation_strings":["3Hifibio, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hifibio, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051550612","display_name":"Roshan Kumar","orcid":"https://orcid.org/0000-0003-0604-0217","observed_orcids":["https://orcid.org/0000-0003-0604-0217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roshan Kumar","raw_affiliation_strings":["3Hifibio, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hifibio, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009080899","display_name":"Nicola Beltraminelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicola Beltraminelli","raw_affiliation_strings":["1Hifibio, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hifibio, Paris, France;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011869192","display_name":"St\u00e9phanie Beq","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"St\u00e9phanie Beq","raw_affiliation_strings":["1Hifibio, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Hifibio, Paris, France;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"6532","last_page":"6532"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.800000011920929},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.8309999704360962},{"id":"https://openalex.org/keywords/cd44","display_name":"CD44","score":0.9980000257492065},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8709999918937683},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8119999766349792},{"id":"https://openalex.org/keywords/leukemia-stem-cells","display_name":"leukemia stem cells","score":0.6140000224113464},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.6330000162124634},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.5899999737739563},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8040000200271606},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8489999771118164},{"id":"https://openalex.org/keywords/single-cell-analysis","display_name":"single-cell analysis","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6820200681686401},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6129757165908813},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5933400392532349},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5616243481636047},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5562853813171387},{"id":"https://openalex.org/C2780932548","wikidata":"https://www.wikidata.org/wiki/Q1056532","display_name":"CD44","level":3,"score":0.5120413899421692},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49070489406585693},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.480878621339798},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4185771346092224},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3836965560913086},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3364573121070862},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3114287257194519},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11288365721702576},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1538-7445.am2020-6532","doi":"https://doi.org/10.1158/1538-7445.am2020-6532","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6532","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:uni-augsburg.opus-bayern.de:113056","doi":null,"is_oa":false,"landing_page_url":"https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/113056","pdf_url":null,"source":{"id":"https://openalex.org/S4306400930","display_name":"OPUS (Augsburg University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I119916105","host_organization_name":"Augsburg University","host_organization_lineage":["https://openalex.org/I119916105"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3180488565","https://openalex.org/W4220953220","https://openalex.org/W2890071829","https://openalex.org/W4389480769","https://openalex.org/W4318831089","https://openalex.org/W2761023000","https://openalex.org/W7148551605","https://openalex.org/W7009765336","https://openalex.org/W4404321925","https://openalex.org/W4281684575"],"abstract_inverted_index":{"Abstract":[0],"Although":[1],"monoclonal":[2,111],"antibodies":[3],"targeting":[4,90],"immune":[5,438],"checkpoints":[6],"have":[7,162,315],"demonstrated":[8,221],"clinical":[9,102,401],"success":[10],"in":[11,22,53,70,104,154,169,259,279,403,440],"a":[12,23,49,94,110,155,216,248,276,283,291,317,397],"range":[13],"of":[14,25,73,146,176,193,200,268,293,307,377,390,447,451],"tumor":[15,55,131,360,442],"types,":[16],"sustained":[17],"responses":[18],"are":[19,262],"only":[20],"observed":[21],"fraction":[24],"patients":[26],"due":[27],"to":[28,33,61,97,117,165,252,264,274,339,344,346,358,386,436],"primary":[29,332],"or":[30],"secondary":[31],"resistance":[32,99],"treatment.":[34],"Recent":[35],"evidence":[36,374],"has":[37,67,215,271],"implicated":[38],"the":[39,54,144,191,266,369,388,441,448,452],"pleiotropic":[40],"immunosuppressive":[41,383],"modulator":[42],"Galactoside-binding":[43],"lectin":[44],"Galectin":[45],"9":[46],"(Gal-9)":[47],"as":[48,79,230,232,281,396],"key":[50,382],"factor":[51,285],"present":[52,109],"microenvironment":[56,443],"that":[57,89,114,297,354,375],"renders":[58],"tumors":[59],"resistant":[60],"current":[62,391],"immunotherapies.":[63],"High":[64,244],"Gal-9":[65,91,119,125,127,140,147,270,298,378,433],"expression":[66],"been":[68,163,272],"reported":[69,273],"different":[71],"types":[72],"cancer":[74,106],"including":[75],"hematological":[76],"malignancies":[77],"such":[78],"AML":[80,280,308,331,366,404],"and":[81,83,100,126,133,138,152,171,189,205,211,239,290,335,393,405,462],"ALL,":[82],"multiple":[84],"solid":[85],"tumors.":[86],"We":[87,108],"hypothesize":[88],"may":[92],"represent":[93],"valuable":[95],"strategy":[96],"overcome":[98],"improve":[101],"response":[103],"selected":[105],"patients.":[107,309,367],"antibody,":[112],"HFB9-2,":[113,201],"specifically":[115],"binds":[116],"human":[118,130,177],"with":[120,136,148,182,379],"sub-nanomolar":[121],"affinity,":[122],"recognizes":[123],"recombinant":[124],"produced":[128],"by":[129],"cells,":[132],"is":[134],"cross-reactive":[135],"mouse":[137],"monkey":[139],"orthologs.":[141],"HFB9-2":[142,183],"blocks":[143,381],"interaction":[145],"its":[149,209],"receptors":[150,161],"TIM3":[151],"CD44":[153],"dose":[156,250],"dependent":[157],"manner.":[158],"These":[159],"two":[160],"described":[164],"mediate":[166],"Gal-9-immunosuppressive":[167],"signals":[168],"effector":[170],"regulatory":[172,194],"T":[173,195],"cells.":[174,196],"Treatment":[175],"PBMCs":[178],"from":[179],"healthy":[180],"donors":[181],"prevents":[184],"Gal-9-induced":[185],"Th1":[186],"cell":[187],"apoptosis":[188],"suppresses":[190],"expansion":[192],"A":[197,431],"humanized":[198],"variant":[199],"HFB9-2hz11,":[202],"was":[203],"generated":[204],"further":[206],"characterized":[207],"for":[208,223,233,286,305,351,365,400,455],"stability":[210,222],"pharmacokinetic":[212],"profile.":[213,219],"HFB9-2hz11":[214,380,395],"favorable":[217],"developability":[218],"It":[220],"at":[224,228,236],"least":[225],"14":[226],"days":[227],"40\u00b0C,":[229],"well":[231],"several":[234,241,257],"hours":[235],"low":[237],"pH,":[238],"following":[240,247],"freeze-thaw":[242],"cycles.":[243],"plasma":[245],"exposures":[246],"single":[249],"administration":[251],"mice":[253],"were":[254],"observed.":[255],"Furthermore,":[256],"preclinical":[258],"vivo":[260],"studies":[261],"ongoing":[263],"demonstrate":[265],"efficacy":[267,389],"HFB-2hz11.":[269],"play":[275],"dual":[277],"role":[278],"both":[282],"self-renewal":[284],"leukemic":[287],"stem":[288],"cells":[289,334],"suppressor":[292],"anti-cancer":[294],"immunity,":[295],"suggesting":[296],"neutralization":[299,376],"represents":[300],"an":[301],"attractive":[302],"therapeutic":[303],"approach":[304],"treatment":[306],"To":[310],"explore":[311],"this":[312],"hypothesis,":[313],"we":[314],"initiated":[316],"predictive":[318],"biomarker":[319],"discovery":[320],"effort,":[321],"using":[322,330],"HiFiBiO's":[323],"proprietary":[324],"Drug":[325],"Intelligent":[326],"Science":[327],"(DIS\u2122)":[328],"platform,":[329],"patient":[333,341,352],"integrating":[336],"single-cell":[337],"technology":[338],"identify":[340],"subpopulations":[342],"likely":[343],"respond":[345],"HFB9-2hz11.":[347],"Potential":[348],"novel":[349,432],"biomarkers":[350],"stratification,":[353],"could":[355],"be":[356,363],"applied":[357],"other":[359,406],"indications,":[361],"will":[362],"identified":[364],"Altogether,":[368],"data":[370],"presented":[371],"here":[372],"provide":[373],"mechanisms":[384],"known":[385],"limit":[387],"immunotherapies":[392],"position":[394],"drug":[398],"candidate":[399],"exploration":[402],"indications.":[407],"Citation":[408],"Format:":[409],"Germain":[410],"Margall,":[411],"Rachel":[412],"Pacherie,":[413],"Julie":[414],"Prigent,":[415],"He":[416],"Zhou,":[417],"Francisco":[418],"Adrian,":[419],"Liang":[420],"Schweizer,":[421],"Andreas":[422],"Raue,":[423],"Roshan":[424],"Kumar,":[425],"Nicola":[426],"Beltraminelli,":[427],"St\u00e9phanie":[428],"Beq.":[429],"HFB9-2:":[430],"neutralizing":[434],"antibody":[435],"reverse":[437],"suppression":[439],"[abstract].":[444],"In:":[445],"Proceedings":[446],"Annual":[449],"Meeting":[450],"American":[453],"Association":[454],"Cancer":[456,468],"Research":[457],"2020;":[458],"2020":[459],"Apr":[460],"27-28":[461],"Jun":[463],"22-24.":[464],"Philadelphia":[465],"(PA):":[466],"AACR;":[467],"Res":[469],"2020;80(16":[470],"Suppl):Abstract":[471],"nr":[472],"6532.":[473]},"counts_by_year":[],"updated_date":"2026-10-11T09:32:39.932853","created_date":"2020-09-11T00:00:00"}